Rapoff Michael A
Department of Pediatrics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160-7330, USA.
Best Pract Res Clin Rheumatol. 2006 Apr;20(2):301-14. doi: 10.1016/j.berh.2005.11.002.
Medical treatment regimens for pediatric rheumatic diseases are complex, have delayed beneficial effects, and require consistent adherence over a long period of time. All of these factors place patients at risk for non-adherence that can compromise the benefits of treatment and the long-term health and quality of life for patients. This chapter provides a definition of adherence and reviews the prevalence of non-adherence to regimens for pediatric rheumatic diseases. It also describes various methods for assessing adherence, including assays, observation, electronic monitoring, pill counts, and provider or patient ratings of adherence. Studies which identify risk factors for non-adherence are also reviewed, with suggestions on how these risk factors might be addressed. The final section reviews the few studies that have reported on efforts to improve adherence to regimens for pediatric rheumatic diseases and offers strategies for providers to promote adherence with their patients.
儿科风湿性疾病的治疗方案复杂,有益效果出现延迟,且需要长期持续坚持。所有这些因素都使患者面临不依从治疗的风险,这可能会损害治疗效果以及患者的长期健康和生活质量。本章给出了依从性的定义,并综述了儿科风湿性疾病治疗方案的不依从率。还描述了评估依从性的各种方法,包括化验、观察、电子监测、药片计数以及医疗服务提供者或患者对依从性的评级。本章也综述了确定不依从风险因素的研究,并就如何应对这些风险因素提出了建议。最后一部分综述了少数关于提高儿科风湿性疾病治疗方案依从性的研究,并为医疗服务提供者提供了促进患者依从治疗的策略。